We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Netscientific Plc | NSCI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -2.00 | -2.90% | 67.00 | 09:03:24 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 69.00 | 67.00 | 69.00 | 67.00 | 69.00 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 07/7/2024 00:17 by kingston78 My previous summary that the company was trading at the top of its band at 79 p has been proven correct. The share price has since dropped back to 70-72 p.A wife was complaining to her friends that whilst her husband's business was doing well she did not see any improvement in their standard of living. Some years later when her husband cashed in his business they suddenly became cash millionaires. NSCI (or rather us investors)is like the wife described above. Asset rich but cash poor. Dragon's Den will ask a simple question, "show me the cash". Value may rise and value may fall. Only cash is king. As reiterated before, NSCI will only rise substantially if a large investor continues to buy its shares to push up the price, or a large profitable cash exit from one or more of its investments will pave the way upwards. Small investors have little influence. |
Posted at 26/6/2024 18:17 by kingston78 NSCI is always lightly traded, so there cannot be many followers or new investors. I think that there is a lack of promotion to the right audience.Despite MM has marked down the price by 1p today the spread has narrowed from 6p to only 1 p (72-73p). It would appear that MM wants sellers to sell them the stock, as they keep a tight book. In this respect, any pent up demand generated by, for example, an investment recommendation by IC or others, will raise the share price by a few pence. Anyway, as I have iterated before, unless and until the company has realised real cash in exiting one or more of its investments the share price will reach 90 p - 100 p at best in the next few months. If achieved, that is not a bad return. Years ago, I realised that investment trusts were mostly trading at a discount to their underlying assets whilst Unit Trusts were trading at a premium. This is a perception issue. NSCI is acting like an investment trust, investing in a number of companies that may generate a good return. I have no doubt in my mind that one day, we only need a blockbuster to increase the value of NSCI many folds. We live in hope. |
Posted at 25/6/2024 14:34 by kingston78 It may not be appropriate for me to suggest other shares on this thread, but I would like my fellow investors to make money. I am convinced that Genedrive (GDR) and Polarean (POLX) are both about to take off. You can double your money in both of them in quick order.PLEASE DYOR. Good luck. |
Posted at 14/6/2024 13:50 by loafofbread One of our Martlet Investments. £29M!Echion raises £29 million in Series B investment round June 14, 2024 Series B fundraise of £29 million led by Volta Energy Technologies with CBMM, BGF and Cambridge Enterprise Ventures The world’s leading developer of niobium-based, fast-charging battery materials, Echion Technologies, has successfully completed its Series B funding round, raising £29 million in investment capital. The round was led by specialist battery and energy storage technology investor Volta Energy Technologies (Volta), with participation from existing investors CBMM, BGF, and Cambridge Enterprise Ventures. The investment will enable Echion to execute its go-to-market strategy to see its innovative niobium-based XNO® anode material utilised in real world applications, at volume. Echion is Volta’s first investment into a European headquartered company and having Volta as the lead Series B investor highlights Echion as a rising British battery technology business within the crucial global energy storage industry. Echion’s longstanding partnership with the world’s leading producer of niobium, CBMM, will see the opening of a 2,000 tonne per year XNO® manufacturing facility this year. This provides Echion with the manufacturing capacity to satisfy the large and growing demand for XNO® across its global customer base comprised of major cell manufacturers and original equipment manufacturers (OEMs). |
Posted at 13/6/2024 11:25 by loafofbread Great results and a pretty good presentation that answered most of the questions.Decent involvement from a number of people. Panmure note on it's way which would be a first. £35.6M plus £4M since year end so £40M vs £15M. No reason for this not to steadily move higher as news flow and investor interest increases. |
Posted at 13/6/2024 11:18 by kingston78 The important factor was that when PDSB was at a high of US$14 the share price of NSCI had hardly progressed. Subsequent events have shown that NSCI has become a more rounded investment companies with a promising portfolio of high tech companies at their early stage. Moreover, NSCI does not contribute much in cash term the advancement of those companies, which rely on external funding, which at a higher subscription price, actually adds value to NSCI despite the fact that they are unlisted. One of these days there will be a profitable exit, or exits, and investors will see that NSCI has many gems. This is akin to some people who are asset rich but cash poor.I am just concerned that NSCI will not have sufficient cash to run its corporate activities and resort to a discounted fund raising itself. |
Posted at 13/6/2024 08:22 by loafofbread £40M of assets valued at £15M and people sell!They really need to come up with some ideas on how to attract investors as the Aim mms just kill them. |
Posted at 05/6/2024 12:02 by loafofbread EMV CAPITAL LEADS C.£3.4 MILLION FOLLOW-ON INVESTMENT INTO SATCOM LEADER SOFANT05.06.2024 EMV Capital Funding to facilitate terminal delivery to key clients in growing SatCom market for commercial and government applications EMV Capital (“EMVC”) The fundraising was led by EMV Capital, syndicated from its cohort of private EIS investors, and joined by Kelvin Capital and Scottish Enterprise. The company is now set to execute its go-to-market strategy, using funds from this investment round to deliver satellite terminals to SatCom operators and their clients in aerospace, defence and security and civilian applications. Sofant has made significant product commercialisation progress, including development contracts with Inmarsat (now part of Viasat), the European Space Agency and a global defence company. Sofant’s proprietary technology enables operators to enhance their network capabilities and expand service offerings for both commercial and government applications. The company’s proprietary RF MEMS technology facilitates the development of a highly efficient radio platform that directly addresses the most difficult size, weight and power consumption challenges facing future wireless communication systems. Dr Ilian Iliev, Managing Director of EMV Capital and Sofant Board member, commented: “We are pleased with the success of this fundraising for Sofant that comes at a critical value inflection point for the company. In line with our capital-light investment strategy, we worked with management and our co-investors to develop the right funding structure for the company as it accelerates development. It is pleasing to see a UK-born semiconductor company make an impact on the global stage as a key enabler for future wireless networks with a growing number of commercial and government applications. We look forward to continuing our important work with the company.” David Wither, CEO of Sofant, also commented: “We continue to see strong and increasing interest in our target markets from both customers and prospective new investors. Sofant will use the proceeds from this investment round to deliver fully integrated SatCom terminals to our lead customers for network trials before the end of this year. This milestone represents a key value inflection point and the culmination of many years of development work. We thank EMV Capital and all our investors for their continued support. We look forward to a transformational year, and anticipate the launch of our first SatCom terminal which promises to transform the SatCom industry.’R |
Posted at 30/4/2024 20:13 by loafofbread EMV post says Ventive has just raised another £1M. Would suggest an RNS is due?06 November 2023 NetScientific plc ("NetScientific" or the "Company") Heat pump specialist Ventive secures c.GBP900,000 investment NetScientific Plc (AIM: NSCI), the deep tech and life sciences VC investment group, announces that its portfolio company Ventive has successfully closed a c.GBP900,000 investment ("Investment"). The Investment included GBP316,000 from existing shareholders and the conversion of two existing convertible loans (and interest thereon) valued at c.GBP600,000. This is the first closing as part of Ventive's proposed GBP1 million to GBP1.5 million investment programme, with further new investment anticipated prior to 30 April 2024 in one or more additional closings. This additional funding is complemented by ongoing non-dilutive funding from, amongst other grants awarded, a GBP1.5 million BEIS grant secured in 2022, as well as a recently awarded GBP100,000 UK Government grant focused on 'net zero HVAC' systems. The Investment was led and syndicated by EMV Capital, the Company's wholly owned venture capital and corporate finance firm. It follows the initial investment led and syndicated by EMV Capital that was announced (via RNS Reach) on 20 October 2022, where EMV Capital secured an initial c.16% stake in partial settlement of its fees. Since that initial investment, the value creation team of EMV Capital has worked closely with Ventive to stabilise and develop its business plan and product range. The proceeds of the Investment will support the completion of the design and test phase and factory build for Ventive's modular heat pumps, further enhancements to its passive air ventilation product range, and build-up of its marketing and sales capacity to drive sales of its existing product range. The Ventive balance sheet is also streamlined following the conversion of the convertible loans. Following completion of the Investment, the total equity holding of the NetScientific group in Ventive is 11.0% on a fully diluted basis, which includes the partial settlement of its corporate finance fees relating to the Investment. This holding equates to a post-investment fair value of GBP893,000, a substantial increase of 1,617% from the GBP52,000 reported as at 31 December 2022. In addition, following the introduction of investors to Ventive by EMV Capital under its capital efficient model, NetScientific's capital under advisory with Ventive is now 23.8% of the fully diluted share capital. |
Posted at 18/4/2024 12:16 by kingston78 There are increments in the value of the company's investments, without or with little further capital outlay, as those investments attract external funding.However, these increases in value are not realised and therefore many investors do not give it credence. Only when some or all of those investments are realised by selling them for cash will more investors recognise the true value of NSCI. Looking at past announcements, I feel that it will not be too far away when a total exit from one or more investments will take place. Watch this space for the share price to shoot up without warning. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
